Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats

Journal of the American Society of Nephrology

Volumn 17, Issue 5, 2006, Pages 1395-1404

  Lloberas, Núria ^a   Cruzado, Josep M ^a   Franquesa, Marcella ^a   Herrero Fresneda, Immaculada ^a   Torras, Joan ^a   Alperovich, Gabriela ^a   Rama, Inés ^a   Vidal, August ^a   Grinyó, Josep M ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CONNECTIVE TISSUE GROWTH FACTOR; CYCLINE; INSULIN; LINPLANT; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; STREPTOZOCIN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCULATION; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLOMERULUS; HYPERPLASIA; HYPERTROPHY; LOW DRUG DOSE; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

EID: 33646352217     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005050549     Document Type: Article

References (41)

1. Remuzzi G, Schieppati A, Ruggenenti P: Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med 346: 1145-1151, 2002
2. Mason RM, Wahab NA: Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol 14: 1358-1373, 2003
3. Ziyadeh FN, Sharma K: Overview: Combating diabetic nephropathy. J Am Soc Nephrol 14: 1355-1357, 2003
4. Amos AF, McCarty DJ, Zimmet P: The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med 14[Suppl 5]: S1-S85, 1997
5. Chiarelli F, Trotta D, Verrotti A, Mohn A: Kidney involvement and disease in patients with diabetes. Panminerva Med 45: 23-41, 2003
6. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int 56: 1627-1637, 1999
7. Utimura R, Fujihara CK, Mattar AL, Malheiros DM, Noronha IL, Zatz R: Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes. Kidney Int 63: 209-216, 2003
8. Kahan BD: Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study. The Rapamune US Study Group. Lancet 356: 194-202, 2000
9. Dzau VJ, Braun-Dullaeus RC, Sedding DG: Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat Med 8: 1249-1256, 2002
10. Wolf G, Shankland SJ: P27Kip1: The "rosebud" of diabetic nephropathy? J Am Soc Nephrol 14: 819-822, 2003
11. Awazu M, Omori S, Ishikura K, Hida M, Fujita H: The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy. J Am Soc Nephrol 14: 699-708, 2003
12. Fan YP, Weiss RH: Exogenous attenuation of p21(Waf1/Cip1) decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1. J Am Soc Nephrol 15: 575-584, 2004
13. Kawamata S, Sakaida H, Hori T, Maeda M, Uchiyama T: The upregulation of p27Kip1 by rapamycin results in G1 arrest in exponentially growing T-cell lines. Blood 91: 561-569, 1998
14. Nagai KAH, Matsubara T, Mima A, Sumi E, Kanamori H, Yanahita M, Iehara N, Fukatsu A, Kita T, Doi T: Akt/ mTOR-mediated mesangial hypertrophy is important in the development of diabetic nephropathy [Abstract]. J Am Soc Nephrol 14: 5A, 2003
15. Komers RZJ, Lindsley JN, Anderson S: Renal cortical expression of Akt kinase is increased in Zucker diabetic fatty rats and controls mTOR phosphorylation [Abstract]. J Am Soc Nephrol 15: SU-PO890, 2004
16. Runyan CE, Schnaper HW, Poncelet AC: The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-beta1. J Biol Chem 279: 2632-2639, 2004
17. Choudhury GG: A linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase Cepsilon, and MAPK in mesangial cells regulates interferon-gamma-induced STAT1alpha transcriptional activation. J Biol Chem 279: 27399-27409, 2004
18. Wang W, Chan YH, Lee W, Chan L: Effect of rapamycin and FK506 on mesangial cell proliferation. Transplant Proc 33: 1036-1037, 2001
19. Lock HSS, Robson MG: Non-immunosuppressives levels of rapamycin inhibit mesangial cell proliferation and extracellular matrix production [Abstract]. J Am Soc Nephrol 15: SA-PO908, 2004
20. Zhang D, Brodt P: Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Oncogene 22: 974-982, 2003
21. Weibel E: Stereological Methods. Practical Methods for Biological Morphometry, London, Academic Press, 1979
22. Lloberas N, Cruzado JM, Torras J, Herrero-Fresneda I, Riera M, Merlos M, Grinyo JM: Protective effect of UR-12670 on chronic nephropathy induced by warm ischaemia in ageing uninephrectomized rats. Nephrol Dial Transplant 16: 735-741, 2001
23. Herrero-Fresneda I, Torras J, Cruzado JM, Condom E, Vidal A, Riera M, Lloberas N, Alsina J, Grinyo JM: Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol 162: 127-137, 2003
24. Yozai K, Shikata K, Sasaki M, Tone A, Ohga S, Usui H, Okada S, Wada J, Nagase R, Ogawa D, Shikata Y, Makino H: Methotrexate prevents renal injury in experimental diabetic rats via anti-inflammatory actions. J Am Soc Nephrol 16: 3326-3338, 2005
25. Marquez B, Zouvani I, Karagrigoriou A, Anastasiades E, Pierides A, Kyriacou K: A simplified method for measuring the thickness of glomerular basement membranes. Ultrastruct Pathol 27: 409-416, 2003
26. Dragun D, Hoff U, Park JK, Qun Y, Schneider W, Luft FC, Haller H: Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 58: 2166-2177, 2000
27. Ueki T, Kaneda Y, Tsutsui H, Nakanishi K, Sawa Y, Morishita R, Matsumoto K, Nakamura T, Takahashi H, Okamoto E, Fujimoto J: Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 5: 226-230, 1999
28. Sassy-Prigent C, Heudes D, Mandet C, Belair MF, Michel O, Perdereau B, Bariety J, Bruneval P: Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49: 466-475, 2000
29. Cruzado JM, Torras J, Riera M, Herrero I, Hueso M, Espinosa L, Condom E, Lloberas N, Bover J, Alsina J, Grinyo JM: Influence of nephron mass in development of chronic renal failure after prolonged warm renal ischemia. Am J Physiol Renal Physiol 279: F259-F269, 2000
30. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69-75, 1998
31. Herrero-Fresneda I, Torras J, Vidal A, Lloberas N, Cruzado JM, Grinyo JM: Reduction of postischemic immune inflammatory response: An effective strategy for attenuating chronic allograft nephropathy. Transplantation 79: 165-173, 2005
32. Tao Y, Kim J, Schrier RW, Edelstein CL: Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol 16: 46-51, 2005
33. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G: Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431: 200-205, 2004
34. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995
35. Hafizi S, Wang X, Chester AH, Yacoub MH, Proud CG: ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Am J Physiol Heart Circ Physiol 287: H1232-H1238, 2004
36. Riesterer O, Zingg D, Hummerjohann J, Bodis S, Pruschy M: Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells. Oncogene 23: 4624-4635, 2004
37. Finckenberg P, Inkinen K, Ahonen J, Merasto S, Louhelainen M, Vapaatalo H, Muller D, Ganten D, Luft F, Mervaala E: Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 163: 355-366, 2003
38. Cruzado JM, Lloberas N, Torras J, Riera M, Filiat C, Herrero-Fresneda I, Aran JM, Alperovich G, Vidal A, Grinyo JM: Regression of advanced diabetic nephropathy by hepatocyte growth factor gene therapy in rats. Diabetes 53: 1119-1127, 2004
39. Yo Y, Morishita R, Yamamoto K, Tomita N, Kida I, Hayashi S, Moriguchi A, Kato S, Matsumoto K, Nakamura T, Higaki J, Ogihara T: Actions of hepatocyte growth factor as a local modulator in the kidney: Potential role in pathogenesis of renal disease. Kidney Int 53: 50-58, 1998
40. Liu Y: Epithelial to mesenchymal transition in renal fibrogenesis: Pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15: 1-12, 2004
41. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003